Form 4 for ARXS Arxis, Inc.
Accepted 2026-04-20 21:07:17 ET · period of report 2026-04-17 · accession 0001193125-26-164673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-20 21:07 | 2026-04-17 | ARXS | Oetgen Stephen Duane | Dir | A - Grant | $0.00 | +5,357 | 5,357 | New | $0 | |
| 2026-04-20 21:07 | 2026-04-17 | ARXS | Oetgen Stephen Duane | Dir | P - Purchase | $28.00 | +25.0K | 30.4K | +467% | +$700.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-04-17 | A | A | 5,357 | $0.00 | 5,357 | D | — | — | (F1) Represents an award of restricted stock units with respect to Class A Common Stock which will vest on the first anniversary of the grant date. |
| 2 | Common | Class A Common Stock | 2026-04-17 | P | A | 25,000 | $28.00 | 30,357 | D | — | — | (F2) Represents shares of Class A Common Stock purchased by the Reporting Person through the directed share program conducted in connection with the Issuer's initial public offering. |